The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Osteoarthritis, Hip

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Osteoarthritis, Hip


High impact information on Osteoarthritis, Hip


Chemical compound and disease context of Osteoarthritis, Hip

  • OBJECTIVE: To evaluate the ability of diacerein, an interleukin-1beta inhibitor, to slow the progressive decrease in joint space width observed in patients with hip osteoarthritis (OA) [10].
  • Ultrasound-guided steroid injections in the treatment of hip osteoarthritis: comment on the letter by Margules [11].
  • Association of nitrate use with risk of new radiographic features of hip osteoarthritis in elderly white women: the study of osteoporotic fractures [12].
  • OBJECTIVE: To estimate and compare the age- and sex-specific prevalence of radiographic hip osteoarthritis (RHOA) in a population-based study of the Pima Indians, using 3 atlas-based methods for assessing features of RHOA [13].
  • Sulindac (cis-5-fluoro-2-methyl-l-[(p-methyl sulfinyl)-benzylidene]-indene-3-acetic acid) is a new nonsteroidal antirheumatic drug recently evaluated in a double-blind trial of 91 patients with hip osteoarthritis [14].

Biological context of Osteoarthritis, Hip


Anatomical context of Osteoarthritis, Hip


Gene context of Osteoarthritis, Hip


Analytical, diagnostic and therapeutic context of Osteoarthritis, Hip


  1. The WOMAC Knee and Hip Osteoarthritis Indices: development, validation, globalization and influence on the development of the AUSCAN Hand Osteoarthritis Indices. Bellamy, N. Clin. Exp. Rheumatol. (2005) [Pubmed]
  2. Low IGF-I levels in hip fracture patients. A comparison of 20 coxarthrotic and 23 hip fracture patients. Hedström, M., Sääf, M., Dalén, N. Acta orthopaedica Scandinavica. (1999) [Pubmed]
  3. A new case of NSAID-induced infertility. Calmels, C., Dubost, J.J., Jasmin-Lebrun, C., Sauvezie, B. Revue du rhumatisme (English ed.) (1999) [Pubmed]
  4. Is a biological marker for osteoarthritis within reach? Chevalier, X. Revue du rhumatisme (English ed.) (1997) [Pubmed]
  5. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Loughlin, J., Dowling, B., Chapman, K., Marcelline, L., Mustafa, Z., Southam, L., Ferreira, A., Ciesielski, C., Carson, D.A., Corr, M. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  6. Association of higher levels of serum cartilage oligomeric matrix protein and N-telopeptide crosslinks with the development of radiographic hip osteoarthritis in elderly women. Kelman, A., Lui, L., Yao, W., Krumme, A., Nevitt, M., Lane, N.E. Arthritis Rheum. (2006) [Pubmed]
  7. Evidence for a role of the genomic region of the gene encoding for the alpha1 chain of type IX collagen (COL9A1) in hip osteoarthritis: A population-based study. Alizadeh, B.Z., Njajou, O.T., Bijkerk, C., Meulenbelt, I., Wildt, S.C., Hofman, A., Pols, H.A., Slagboom, P.E., Duijn, C.M. Arthritis Rheum. (2005) [Pubmed]
  8. Type I collagen alpha1 Sp1 transcription factor binding site polymorphism is associated with reduced risk of hip osteoarthritis defined by severe joint space narrowing in elderly women. Lian, K., Zmuda, J.M., Nevitt, M.C., Lui, L., Hochberg, M.C., Greene, D., Li, J., Wang, J., Lane, N.E. Arthritis Rheum. (2005) [Pubmed]
  9. Progression of radiographic hip osteoarthritis over eight years in a community sample of elderly white women. Lane, N.E., Nevitt, M.C., Hochberg, M.C., Hung, Y.Y., Palermo, L. Arthritis Rheum. (2004) [Pubmed]
  10. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Dougados, M., Nguyen, M., Berdah, L., Maziéres, B., Vignon, E., Lequesne, M. Arthritis Rheum. (2001) [Pubmed]
  11. Ultrasound-guided steroid injections in the treatment of hip osteoarthritis: comment on the letter by Margules. Karim, Z., Brown, A.K., Quinn, M., Wakefield, R.J., Conaghan, P.G., Emery, P., O'Connor, P.J. Arthritis Rheum. (2004) [Pubmed]
  12. Association of nitrate use with risk of new radiographic features of hip osteoarthritis in elderly white women: the study of osteoporotic fractures. Lane, N.E., Williams, E.N., Hung, Y.Y., Hochberg, M.C., Cummings, S.R., Nevitt, M.C. Arthritis Rheum. (2003) [Pubmed]
  13. Hip osteoarthritis prevalence estimates by three radiographic scoring systems. Hirsch, R., Fernandes, R.J., Pillemer, S.R., Hochberg, M.C., Lane, N.E., Altman, R.D., Bloch, D.A., Knowler, W.C., Bennett, P.H. Arthritis Rheum. (1998) [Pubmed]
  14. A multicenter trial of sulindac in osteoarthritis of the hip. Calabro, J.J., Andelman, S.Y., Caldwell, J.R., Gerber, R.C., Hamaty, D., Kaplan, H., Maltz, B.A., Parsons, J.L., Saville, P., Tretbar, H.C., Ward, J.R. Clin. Pharmacol. Ther. (1977) [Pubmed]
  15. Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Schött, U., Sollén, C., Axelsson, K., Rugarn, P., Allvin, I. Acta anaesthesiologica Scandinavica. (1995) [Pubmed]
  16. Bone turnover markers and cytokines in joint fluid: analyses in 10 patients with loose hip prosthesis and 39 with coxarthrosis. Sypniewska, G., Lis, K., Bilinski, P.J. Acta orthopaedica Scandinavica. (2002) [Pubmed]
  17. Levels of chondroitin sulfate isomers in synovial fluid of patients with hip osteoarthritis. Yamada, H., Miyauchi, S., Hotta, H., Morita, M., Yoshihara, Y., Kikuchi, T., Fujikawa, K. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association. (1999) [Pubmed]
  18. Linkage analysis of candidate genes as susceptibility loci for osteoarthritis-suggestive linkage of COL9A1 to female hip osteoarthritis. Mustafa, Z., Chapman, K., Irven, C., Carr, A.J., Clipsham, K., Chitnavis, J., Sinsheimer, J.S., Bloomfield, V.A., McCartney, M., Cox, O., Sykes, B., Loughlin, J. Rheumatology (Oxford, England) (2000) [Pubmed]
  19. Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study. Conrozier, T., Saxne, T., Fan, C.S., Mathieu, P., Tron, A.M., Heinegård, D., Vignon, E. Ann. Rheum. Dis. (1998) [Pubmed]
  20. The CALM1 core promoter polymorphism is not associated with hip osteoarthritis in a United Kingdom Caucasian population. Loughlin, J., Sinsheimer, J.S., Carr, A., Chapman, K. Osteoarthr. Cartil. (2006) [Pubmed]
  21. Expression of parathyroid hormone related protein in the tissue around loosened hip prostheses. Li, T.F., Santavirta, S., Mandelin, J., Lindroos, L., Virtanen, I., Konttinen, Y.T. Clinical and experimental rheumatology. (2001) [Pubmed]
  22. Polymorphism in signal transduction is a major route through which osteoarthritis susceptibility is acting. Loughlin, J. Current opinion in rheumatology. (2005) [Pubmed]
  23. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Pincus, T., Koch, G., Lei, H., Mangal, B., Sokka, T., Moskowitz, R., Wolfe, F., Gibofsky, A., Simon, L., Zlotnick, S., Fort, J.G. Ann. Rheum. Dis. (2004) [Pubmed]
  24. Treatment of coxarthroses with intraarterial injection of No-Spa + Lidocaine. Belley, E. Therapia Hungarica (English edition) (1980) [Pubmed]
  25. Efficacy and tolerability of ketoprofen 200 mg controlled-release cps vs indomethacin 50 mg cps in patients with symptomatic hip osteoarthritis. A multicentre study. Marcolongo, R., Canesi, B., Ferri, S., Oriente, P., Perpignano, G., Serni, U., Tirri, G., Trotta, F., Dal Prà, A., Lucchini, M. Minerva Med. (1997) [Pubmed]
WikiGenes - Universities